Table 2 Detection atrial fibrillation and the effect of treatment in the two monitoring groups
Outcome | Patch-based monitoring (ACTIVE) (n = 43) | Short-duration Holter (CONTROL) (n = 47) | P value | Odds ratio (95% CI) |
|---|---|---|---|---|
Number (percentage) | ||||
Primary outcome | ||||
Detection of PAF with duration ≥ 30 s at 90 days (inter-subject comparison) | 7 (16.3) | 1 (2.1) | 0.026 | 8.9 (1.1–76.0) |
Secondary outcomes | ||||
Detection of PAF with duration ≥ 30 s at 28 days | 6 (14.0) | 1 (2.1) | 0.051 | 7.5 (0.9–64.7) |
Anticoagulation therapy use at 90 days | 7 (16.3) | 1 (2.1) | 0.026 | 8.9 (1.1–76.0) |
Second ischaemic stroke or TIA at 90 days | 1 (2.3) | 1 (2.1) | 1.00 | 1.1 (0.1–18.1) |
Mortality at 90 days | 1 (2.3) | 0 (0) | 0.48 | – |